Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- HSTO
- Price
- 0.03
- Stock movement up
- +- (%)
- Company name
- Histogen Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 115.34K
- Ent value
- -3.04M
- Price/Sales
- 6.07
- Price/Book
- 0.03
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- -92.06%
- 3 year return
- -82.68%
- 5 year return
- -80.01%
- 10 year return
- -65.40%
Last updated: 2025-04-11
DIVIDENDS
HSTO does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 6.07 |
| Price to Book | 0.03 |
| EV to Sales | -160.25 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 4.27M |
| EPS (TTM) | -2.90 |
| FCF per share (TTM) | -2.36 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 19.00K |
| Gross profit (TTM) | 19.00K |
| Operating income (TTM) | -12.05M |
| Net income (TTM) | -12.41M |
| EPS (TTM) | -2.90 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | 100.00% |
| Operating margin (TTM) | -63447.37% |
| Profit margin (TTM) | -65294.74% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 4.57M |
| Net receivables | 0.00 |
| Total current assets | 5.46M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 5.82M |
| Accounts payable | 386.00K |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 1.35M |
| Total liabilities | 1.41M |
| Shareholder's equity | 4.40M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -10.07M |
| Capital expenditures (TTM) | 1.00K |
| Free cash flow (TTM) | -10.07M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -281.70% |
| Return on Assets | -213.27% |
| Return on Invested Capital | -281.70% |
| Cash Return on Invested Capital | -228.77% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 0.03 |
| Daily high | 0.03 |
| Daily low | 0.03 |
| Daily Volume | 0K |
| All-time high | 2850.00 |
| 1y analyst estimate | 2.00 |
| Beta | 1.12 |
| EPS (TTM) | -2.90 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| HSTO | S&P500 | |
| Current price drop from All-time high | -100.00% | -0.86% |
| Highest price drop | -100.00% | -56.47% |
| Date of highest drop | 12 Dec 2024 | 9 Mar 2009 |
| Avg drop from high | -80.77% | -11.07% |
| Avg time to new high | 414 days | 12 days |
| Max time to new high | 2779 days | 1805 days |
COMPANY DETAILS
Marketcap
115.34K
Marketcap category
Small-cap
Description
Histogen Inc., a clinical-stage therapeutics company, focuses on developing clinical and preclinical small molecule pan-caspase and caspase selective inhibitors that protect the body's natural process to restore immune function. The company's product candidates include emricasan for the treatment of acute bacterial skin and skin structure infections, as well as other infectious diseases. Its preclinical product candidates include CTS-2090 and CTS-2096, which are selective small molecule inhibitors of caspase-1 designed for the treatment of various inflammatory diseases. Histogen Inc. was founded in 2007 and is based in San Diego, California. On April 18, 2024, Histogen Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of California.
Employees
7
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner